Cargando…
First report of dabigatran reversal in iatrogenic pericardial tamponade during catheter ablation of atrial fibrillation
Autores principales: | Miller, Jared D., Brinker, Jeffrey A., Spragg, David D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741803/ https://www.ncbi.nlm.nih.gov/pubmed/29296576 http://dx.doi.org/10.1016/j.hrcr.2017.07.006 |
Ejemplares similares
-
Use of idarucizumab for dabigatran reversal in cardiac tamponade during atrial fibrillation ablation: A case report
por: Yoshizawa, Tomoharu, et al.
Publicado: (2019) -
Direct autotransfusion in the management of acute pericardial tamponade during catheter ablation for atrial fibrillation: An imperfect but practical method
por: Zhao, Xin, et al.
Publicado: (2022) -
Intra-pericardial thrombin injection as bailout strategy in iatrogenic pericardial tamponade
por: Rottländer, D., et al.
Publicado: (2022) -
Midterm outcomes of catheter ablation for atrial fibrillation in patients with cardiac tamponade
por: Yui, Yoshiaki, et al.
Publicado: (2018) -
Constrictive pericarditis following atrial fibrillation catheter ablation with cardiac tamponade
por: Fukasawa, Kohki, et al.
Publicado: (2021)